Physician profile
Hal L Chadow
NPI 1669466835
$50,162.83
in general payments reported to CMS, 2019-2025
60 companies · $7,323 in 2025
The $7,323 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,012 · 2020: $1,909 · 2021: $3,217 · 2022: $15K · 2023: $9,525 · 2024: $9,542 · 2025: $7,323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,380 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,800 · Travel and Lodging: $5,809 · Consulting Fee: $4,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,379.89 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,800.00 |
| Travel and Lodging | $5,809.46 |
| Consulting Fee | $4,400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $27,295.20 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $4,511.85 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Abbott Laboratories | $2,578.82 | 2019-2025 | Dragonfly Opstar, Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Penumbra, INC. | $2,047.63 | 2019-2025 | Indigo System |
| Novartis Pharmaceuticals Corporation | $1,846.83 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $967.67 | 2019-2025 | Lifevest |
| Medtronic, INC. | $889.15 | 2021-2024 | Symplicity G3, Cobalt Dr Mri Surescan, Corevalve Evolut R |
| Abiomed | $884.88 | 2020-2025 | Impella |
| Actelion Pharmaceuticals US, INC. | $833.54 | 2019-2025 | Uptravi, Opsumit |
| Boston Scientific Corporation | $811.17 | 2019-2025 | General - Therapies, Rotapro, General - Balloon Catheters |
| Janssen Pharmaceuticals, INC | $714.85 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $649.86 | 2019-2025 | Verquvo, Winrevair |
| Astrazeneca Pharmaceuticals Lp | $609.84 | 2019-2025 | Farxiga |
| Canon Medical Systems USA, INC. | $544.56 | 2025 | Interventional Angiography System |
| Pfizer INC. | $485.32 | 2019-2025 |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hal Chadow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.